Cargando…

Effect of Renin-Angiotensin System Blockade on Insulin Resistance and Inflammatory Parameters in Patients With Impaired Glucose Tolerance

OBJECTIVE: The study investigated the effect of angiotensin receptor blockers (ARB) on glucose homeostasis and inflammatory parameters in patients with impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS: We prospectively studied the insulin sensitivity index (ISI) and homeostasis model as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pscherer, Stefan, Heemann, Uwe, Frank, Helga
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845051/ https://www.ncbi.nlm.nih.gov/pubmed/20086255 http://dx.doi.org/10.2337/dc09-1381

Ejemplares similares

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
por: Bloch, Michael J.
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Risk of lung cancer and renin–angiotensin blockade: a concise review
por: Rachow, Tobias, et al.
Publicado: (2020)

Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020)

The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates the Intrarenal Renin-Angiotensin System
por: Kim, Suyeon, et al.
Publicado: (2006)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics
por: Gismondi, Ronaldo Altenburg, et al.
Publicado: (2015)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
por: Kim, Junghyun, et al.
Publicado: (2016)

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection
por: Salah, Husam M., et al.
Publicado: (2020)

Effect of Renin-Angiotensin System Blockade on Mortality in Korean Hypertensive Patients with Proteinuria
por: Oh, Hyung Jung, et al.
Publicado: (2019)

Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes
por: Silva, Mauro G., et al.
Publicado: (2022)

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance
por: Aoyama-Sasabe, Sae, et al.
Publicado: (2016)

Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
por: Harindhanavudhi, Tasma, et al.
Publicado: (2011)

Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma
por: Tanaka, N, et al.
Publicado: (2012)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
por: Han, Jin, et al.
Publicado: (2021)

Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease
por: Wamkpah, Nneoma, et al.
Publicado: (2022)

Multimodal Blockade of the Renin-Angiotensin System Is Safe and Is a Potential Cancer Treatment for Cats
por: Munday, John S., et al.
Publicado: (2022)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy
por: Abe, Michiaki, et al.
Publicado: (2015)

Unilateral ureteric obstruction: Role of renin angiotensin system blockade on renal recovery: An experimental study
por: Sinha, Anand, et al.
Publicado: (2012)

You are what you Eat: Dietary Salt Intake and Renin Angiotensin Blockade in Diabetic Nephropathy
por: Charytan, David M., et al.
Publicado: (2012)

The dual blockade of the renin–angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration
por: Zwiech, Rafał, et al.
Publicado: (2012)

Comparison of spironolactone and trichlormethiazide as add‐on therapy to renin–angiotensin blockade for reduction of albuminuria in diabetic patients
por: Hase, Michiyo, et al.
Publicado: (2013)

Acute kidney injury: an acceptable risk of treatment with renin-angiotensin system blockade in primary care?
por: Bedford, Michael, et al.
Publicado: (2015)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
por: Yang, Byeong Yun, et al.
Publicado: (2012)

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
por: Bandak, Ghassan, et al.
Publicado: (2017)

Renin‐Angiotensin System Blockade in Aortic Stenosis: Implications Before and After Aortic Valve Replacement
por: Goel, Sachin S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d7lo6kk2e917dsgom1cik6e0tt